Norcantharidin (NCTD) can also regulate ferroptosis by acting on the NRF2/HO-1/GPX4/xCT axis, leading to ferroptosis of ovarian cancer cells by inhibiting NRF2 (38). This evidence concerns the gene GPX4 and ovarian carcinoma.